Connection
Michael Narkewicz to Immunosuppressive Agents
This is a "connection" page, showing publications Michael Narkewicz has written about Immunosuppressive Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.030 |
|
|
|
-
Shepherd RW, Turmelle Y, Nadler M, Lowell JA, Narkewicz MR, McDiarmid SV, Anand R, Song C. Risk factors for rejection and infection in pediatric liver transplantation. Am J Transplant. 2008 Feb; 8(2):396-403.
Score: 0.013
-
Holmes RD, Orban-Eller K, Karrer FR, Rowe DT, Narkewicz MR, Sokol RJ. Response of elevated Epstein-Barr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome. Transplantation. 2002 Aug 15; 74(3):367-72.
Score: 0.009
-
Feranchak AP, Tyson RW, Narkewicz MR, Karrer FM, Sokol RJ. Fulminant Epstein-Barr viral hepatitis: orthotopic liver transplantation and review of the literature. Liver Transpl Surg. 1998 Nov; 4(6):469-76.
Score: 0.007